/GCAN

GCAN Stock - The Greater Cannabis Company, Inc.

Q: What is the analyst price target for GCAN?

Analyst price target information is not currently available for GCAN.

Q: What is GCAN's market cap?

Market capitalization information is not currently available for GCAN.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.08+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.09

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for GCAN

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.74

52W High$3.60

52W Low$0.04

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	N/A	N/A	N/A	$12,630	$48,044
Gross Profit	N/A	$-5,000	$-52,035	$-25	$-46
Gross Margin	N/A	N/A	N/A	-0.2%	-0.1%
Operating Income	$-156,276	$-175,364	$-177,035	$-343,146	$-294,457
Net Income	$-179,041	$-188,402	$-543,501	$-509,809	$-2,578,709
Net Margin	N/A	N/A	N/A	-4036.5%	-5367.4%
EPS	$-0.00	$-0.00	$-0.00	$-0.00	$-0.02

Company Overview

The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company was founded in 2014 and is based in Baltimore, Maryland.

Visit Website

Earnings History & Surprises

GCAN

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$-0.00

Q3 2023

EPS Surprise History

Q1 23

No data

Q2 23

No data

Q3 23

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q3 2023	Sep 30, 2023	—	$-0.00	—	—
Q2 2023	Jun 30, 2023	—	$-0.00	—	—
Q1 2023	Mar 31, 2023	—	$-0.00	—	—

Frequently Asked Questions about GCAN

What is GCAN's current stock price?

The Greater Cannabis Company, Inc. (GCAN) is currently trading at $0.08 per share. The stock has moved +0.00% today.

What is the analyst price target for GCAN?

No analyst price targets are currently available for this stock.

What sector is The Greater Cannabis Company, Inc. in?

The Greater Cannabis Company, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is GCAN's market cap?

The Greater Cannabis Company, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does GCAN pay dividends?

No, The Greater Cannabis Company, Inc. does not currently pay a dividend to shareholders.